EYE-GO A/S is a Danish MedTech start-up established 2015 based on the work by two designers wanting to develop eye-care technologies that improve the quality of life of people around the world suffering from severe and chronic eye conditions. Problem: Only a fraction of patients achieves the full health outcome of treatment due to imperfections with current eye drop bottles. Users experience difficulties instilling the medication, over-dose due to drop size, side-effects and may abandon prescribed treatment plan leading to poor disease management. This is not just an issue for patients who best case loose quality of life and worst case may end up blind, but also for pharma companies whose drugs don’t have full therapeutic effect, and society ending up with unnecessary high health care spending. Solution: MistGo® is a new generation micro-dosing drug delivery system mitigating the imperfections with current eye-drop bottles. MistGo® makes it simple and comfortable to self-administer the drug correctly with the precisely required amount of drug entering the eye at first go, and helps patients adhere to treatment long-term This cutting-edge eye treatment technology from EYE-GO is suitable for long-term eye care diseases requiring topical ocular treatment and is compatible with preservative-free liquids. Leading ophthalmologists and frontrunning international industry players have already name it an “an ophthalmologic game changer”. Visit our website to learn more, or contact us now on HNA@EYE-GO.com (Henrik Nagel, CEO) or RS@EYE-GO.com (Rie Saabye, Director Business Development) to discuss licensing opportunities of an innovative drug delivery system for one or more of your innovative substances.
